Related Experiment Video
Updated: Jun 2, 2026

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
Transcranial Pulse Stimulation Enhances Dexterity in Parkinson's Disease: A Randomized Sham-Controlled Trial
Eva Matt1, Nina Plischek1, Michael Mitterwallner1
1Functional Brain Diagnostics and Therapy, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Summary
Transcranial pulse stimulation (TPS) improved manual dexterity and sensorimotor network function in Parkinson's disease (PD) patients. This non-invasive brain stimulation showed potential as a safe and effective adjunct therapy for PD.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Ultrasound-based neuromodulation offers precise, non-invasive deep brain stimulation.
- It is being explored as a novel treatment for neurological and psychiatric conditions, including Parkinson's disease (PD).
Purpose of the Study:
- To assess the impact of repeated transcranial pulse stimulation (TPS) on motor symptoms, brain structure, and functional activity in PD patients.
- To evaluate TPS as a potential adjunct therapy for Parkinson's disease.
Main Methods:
- A randomized, sham-controlled, double-blind, crossover trial involving 30 mild PD participants.
- Six sessions of verum or sham TPS targeting the sensorimotor network, with assessments at baseline, 1 day, and 1 month post-stimulation.
- Utilized clinical evaluations, functional MRI, and diffusion tensor imaging.
Main Results:
- Significant improvement in manual dexterity (coin rotation task) after verum TPS compared to sham.
- Increased sensorimotor network activation observed with functional MRI following verum TPS.
- Enhanced white matter structural integrity in the primary somatosensory cortex detected via diffusion tensor imaging.
- Gross motor symptoms showed similar improvement with both verum and sham TPS.
Conclusions:
- TPS demonstrates behavioral, neurophysiological, and structural effects within the targeted sensorimotor network.
- TPS may serve as a safe and effective adjunctive treatment for Parkinson's disease.
- Mild and transient adverse events were reported, indicating a favorable safety profile.

